Donnelly-Roberts, DL; Puttfarcken, PS; Kuntzweiler, TA; Briggs, CA; Anderson, DJ; Campbell, JE; Piattoni-Kaplan, M; Mckenna, DG et al. (1998). "ABT-594 (R)-5-(2-azetidinylmethoxy)-2-chloropyridine: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization". The Journal of pharmacology and experimental therapeutics 285 (2): 777–86. PMID 9580626
Bannon, AW; Decker, MW; Curzon, P; Buckley, MJ; Kim, DJ; Radek, RJ; Lynch, JK; Wasicak, JT et al. (1998). "ABT-594 (R)-5-(2-azetidinylmethoxy)-2-chloropyridine: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization". The Journal of pharmacology and experimental therapeutics 285 (2): 787–94. PMID 9580627
Decker, MW; Bannon, AW; Buckley, MJ; Kim, DJ; Holladay, MW; Ryther, KB; Lin, NH; Wasicak, JT et al. (1998). "Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice". European journal of pharmacology 346 (1): 23–33. doi:10.1016/S0014-2999(98)00042-9. PMID 9617748
Kesingland, AC; Gentry, CT; Panesar, MS; Bowes, MA; Vernier, JM; Cube, R; Walker, K; Urban, L (2000). "Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain". Pain 86 (1-2): 113–8. doi:10.1016/S0304-3959(00)00233-5. PMID 10779668
Lynch Jj, 3.; Wade, C.; Mikusa, J.; Decker, M.; Honore, P. (2005). "ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model". European journal of pharmacology 509 (1): 43–48. doi:10.1016/j.ejphar.2004.12.034. PMID 15713428
